R&D How medical supply chains are adapting to global disruptions From the lingering impacts of pandemic-era bottlenecks to geopolitical tensions and extreme weather events, medical supply chains are under pressure.
Market Access Navigating new risks: How China’s Anti-Espionage Law could i... The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential
Digital How to conduct a cybersecurity audit on your pharma supply c... Drug manufacturers, wholesale distributors and pharmacies stepped up during the COVID-19 pandemic to preserve supply chain integrity.
Digital Innovating pharma: How technology can ensure a steady medica... The pharmaceutical industry faces an urgent challenge: frequent drug shortages that threaten patient care and public health.
R&D Supply chain resilience in pharma: Delivering consistency am... In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.
News Appeal finds NICE must reconsider Alzheimer's drugs Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.